FR901464 Analog Synthesis via Olefin Metathesis and Reductive Amination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of potent analogs of the natural product FR901464, known for its anticancer properties, is hindered by a lengthy process involving numerous steps, limiting the development of more effective cancer treatment compounds.
Innovation Solution
The development of novel analogs and improved methods for preparing FR901464 and its derivatives, including specific compounds conforming to Formulas (I) and (II), which involve olefin metathesis catalysts and polyethylene glycol moieties, to enhance cancer cell antiproliferative activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the conventional synthesis method is used to prepare FR901464 analogs, then the antitumor activity can be achieved, but the synthesis process is lengthy and involves numerous steps
Solution Approach 1:
The synthesis is divided into modular segments: preparing Fragment A (with polyethylene glycol moiety), preparing Fragment B (with electrophilic group), and coupling them through reductive amination. This segmentation allows parallel synthesis and optimization of each fragment independently, reducing overall synthesis time while maintaining the antitumor activity of the final analogs.
Solution Approach 2:
The polyethylene glycol moiety is introduced early in the synthesis at Fragment A before coupling, and protective groups are strategically placed on functional groups that would otherwise require complex protection/deprotection sequences. This preliminary action eliminates multiple intermediate steps and simplifies the overall synthesis pathway.
2Manufacturing precision
If the conventional synthesis method is used to prepare FR901464 analogs, then the desired compounds can be obtained, but the number of synthesis steps is large (at least nineteen linear steps and typically forty or more in total)
Solution Approach 1:
Multiple synthetic operations are merged into single steps where possible. The coupling step combines Fragment A and Fragment B through reductive amination in one operation, forming the key imine and reducing it to the amine bond simultaneously. This merging reduces the total step count from forty or more to a much more manageable number while maintaining structural accuracy.
Solution Approach 2:
Fragment A and Fragment B serve as pre-prepared intermediaries with specific functional groups designed for efficient coupling. The electrophilic group on Fragment B and the amine on Fragment A are specifically designed to undergo clean reductive amination, acting as ideal intermediaries that simplify the final coupling step and reduce the need for additional purification and protection steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds demonstrate significant cancer cell antiproliferative activity and RNA splicing inhibition, offering potential therapeutic benefits for various cancers and cellular disorders.
Implementation Method 1
The development of novel analogs and improved methods for preparing FR901464 and its derivatives, including specific compounds conforming to Formulas (I) and (II), which involve olefin metathesis catalysts
Data Source
AI summary
The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.